Skip to main content
SpringerLink
Log in

Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The nitric oxide (NO) synthase inhibitor NG-monomethyl-L-arginine (N-NMMA) and the competitive substrate for NO synthase L-arginine were used to determine the role of endogenous NO on the behavioral and neuroendocrine responsiveness following systemic corticotrophin in dexamethasone-suppressed rats. Corticotrophin (50-200 mU/kg, s.c.) dose-dependently decreased behavioral activity in the actimeter and produced significant anxiolytic and anti-risk activity in the plus-maze behavior test, without affecting systolic blood pressure. Rats given corticotrophin showed significant increased plasma corticosterone and reduced adrenal ascorbic acid level. These behavioral and adrenal responses of corticotrophin were dose dependently blocked by metyrapone (20 and 50 mg/kg, i.p.), an inhibitor of steroid 11β-hydroxylase in adrenal and neural tissues that block steroidogenesis. Intracerebroventricular administration of L-NMMA (20 μg/rat in 10 μl) significantly prevented the behavioral hypoactivity and anxiolytic-like responses of corticotrophin without influencing the adrenal responsiveness. The effect of L-NMMA was completely reversed by preadministration of L-arginine (300 mg/kg, i.p.). These results suggest that neuronal nitric oxide pathway plays an important modulating role in the behavioral effects of corticotrophin by mechanisms other than those involving cardiovascular effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142, 1991

    PubMed  Google Scholar 

  2. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for biological activity of endothelium-derived relaxing factor. Nature 327: 524–526, 1987

    Article  PubMed  Google Scholar 

  3. Reddy DS, Singh M, Chopra K: Signalling mechanisms of cardiac hypertrophy. Ind J Pharmacol 28: 58–71, 1996

    Google Scholar 

  4. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 101: 746–752, 1990

    PubMed  Google Scholar 

  5. Brignola G, Calignano A, Rosa MD: Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br J Pharmacol 133: 1372–1376, 1994

    Google Scholar 

  6. Garthwiate J: Glutamate, nitric oxide and cell signalling in the nervous system. Trends Neurosci 14: 60–67, 1991

    Article  PubMed  Google Scholar 

  7. Bredt DS, Hwang, PM, Snyder SH: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347: 768–770, 1990

    Article  PubMed  Google Scholar 

  8. Meller ST, Dykstra C, Gebhart GF: Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for Nmethyl-D-aspartate-produced facilitation of the nociceptive tail-flick reflex. Eur J Pharmacol 214: 93–96, 1992

    Article  PubMed  Google Scholar 

  9. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulinrequiring enzyme. Proc Natl Acad Sci USA 87: 682–685, 1990

    PubMed  Google Scholar 

  10. Garthwaite J, Garthwaite G, Palmer RMJ, Moncada S: NMDA receptor activation induces nitric oxide synthesis from arginine from rat brain slices. Eur J Pharmacol 172: 413–416, 1989

    Article  PubMed  Google Scholar 

  11. Miki N, Kawabe Y, Kuriyama K: Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun 75: 815–856, 1991

    Google Scholar 

  12. Lonart G, Wang J, Johnson KM: Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol 220: 271–272, 1992

    Article  PubMed  Google Scholar 

  13. Hanbauer I, Win D, Osawa Y, Edelman GM, Gally JA: Role of nitric oxide in NMDA-evoked release of 3H-dopamine from striatal slices. NeuroReport 3: 409–412, 1992

    PubMed  Google Scholar 

  14. Dawson VL, Dawson, TM, London ED, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88: 6368–6371, 1991

    PubMed  Google Scholar 

  15. Schuman EM, Madison DV: A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 254: 1503–1506, 1991.

    PubMed  Google Scholar 

  16. Sandi C, Guaza C: Evidence for nitric oxide-mediated rapid locomotor effects of corticosterone in a novel environment. Ann NY Acad Sci 756: 398–399, 1994

    Google Scholar 

  17. Sandi C, Venero C, Guaza C: Nitric oxide synthesis inhibitors prevent rapid behavioral effects of corticosterone in rats. Neuroendocrinology 63: 446–453, 1996

    PubMed  Google Scholar 

  18. DeWied D, Jolles J: Neuropeptides derived from the pro-opiocortin: Behavioral, physiological and neurochemical effects. Physiol Rev 62: 976–1059, 1982

    PubMed  Google Scholar 

  19. Pranzatelli MR: On the molecular mechanism of adrenocorticotrophic hormone in the CNS: Neurotransmitters and receptors. Exp Neurol 125: 142–161, 1994

    Article  PubMed  Google Scholar 

  20. Baram TZ, Schultz L: ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone. Epilepsia 36: 174–178, 1995

    PubMed  Google Scholar 

  21. Snead OC, Benton JW, Hosey LC, et al.: Treatment of infantile spasms with high-dose ACTH: Efficacy and plasma levels of ACTH and prednisone. Neurology 39: 1027–1031, 1989

    PubMed  Google Scholar 

  22. Hol T, Spruijt BM: The MSH/ACTH (4-9) analog ORG 2766 counteracts isolation-induced changes in social behavior via the amygdala. Peptides 13: 541–544, 1991

    Article  Google Scholar 

  23. Niesink RJM, Van Ree JM: Normalizing effects of an ACTH 4-9 analog (ORG 2766) on ‘disturbed’ social behavior of rats: Implication of endogenous opioid systems. Science 221: 960–962, 1983

    PubMed  Google Scholar 

  24. Kulkarni SK, Reddy DS: Neurosteroids: A new class of neuromodulators. Drugs Today 31: 433–455, 1995

    Google Scholar 

  25. Reddy DS, Kulkarni SK: Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the antistress activity of neurosteroids in mice. Psychopharmacology 128: 280–292, 1996

    Article  PubMed  Google Scholar 

  26. Reddy DS, Kulkarni SK: Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 752: 61–71, 1997

    Article  PubMed  Google Scholar 

  27. Reddy DS, Kulkarni SK: Neurosteroid co-administration prevents development of tolerance and augments recovery from chronic benzodiazepine withdrawal anxiety and hyperactivity in mice. Meth Find Exp Clin Pharmacol 19: 395–405, 1997

    Google Scholar 

  28. Kulkarni SK, Reddy DS: Animal behavioral models for testing antianxiety agents. Meth Find Exp Clin Pharmacol 18: 219–230, 1996

    Google Scholar 

  29. Griebel G, Sanger DJ, Perrault G: The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 124: 245–254, 1996

    PubMed  Google Scholar 

  30. Reddy DS, Singh M, Ghosh S, Ganguly NK: Role of cardiac reninangiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction. Mol Cell Biochem 155: 1–11, 1996

    PubMed  Google Scholar 

  31. James VHT, Mattingly D, Daly JR: Recommended method for the determination of plasma corticosteroids. Brit Med J 197: 310–313, 1971

    Google Scholar 

  32. DeWied D, Ferrari W (eds). Central actions of ACTH and related peptides. Padova: Fidia Research Series, 1986

  33. Jain MR, Patil PP, Subhedar N: Intracranial metyrapone stimulates CRFACTH axis in the teleost, Clarias batrachus: Possible role of neurosteroids. NeuroReport 5: 2093–2096, 1994

  34. Jain MR, Patil PP, Subhedar N: Direct action of metyrapone on brain: Implication in feeding. NeuroReport 5: 69–71, 1993

    Google Scholar 

  35. Weber DM, Eke BC, Maines MD: Corticosterone regulates heme oxygenase-2 and NO synthase transcription and protein expression in rat brain. J Neurochem 63: 953–62, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, 160 014, India

    Doodipala Samba Reddy & S. K. Kulkarni

Authors
  1. Doodipala Samba Reddy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. K. Kulkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reddy, D.S., Kulkarni, S.K. Inhibition of neuronal nitric oxide synthase (n-cNOS) reverses the corticotrophin-induced behavioral effects in rats. Mol Cell Biochem 183, 25–38 (1998). https://doi.org/10.1023/A:1006815125689

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006815125689

Search

Navigation